Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

AML - 1096

Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

Fathima Shehnaz Ayoobkhan

Poster Presenter: Fathima Shehnaz Ayoobkhan

Thumbnail for Myeloablative vs Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide in Haploidentical Hematopoietic Cell Transplantation for AML and MDS: A CIBMTR Registry Analysis

AML - 1104

Myeloablative vs Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide in Haploidentical Hematopoietic Cell Transplantation for AML and MDS: A CIBMTR Registry Analysis

Mohammad Ebad Ur Rehman

Poster Presenter: Mohammad Ebad Ur Rehman

Thumbnail for Racial and Ethnic Differences in Disease Characteristics, Treatment Patterns, and Outcomes in Acute Myeloid Leukemia: A Real-World Single-Center Analysis

AML - 1110

Racial and Ethnic Differences in Disease Characteristics, Treatment Patterns, and Outcomes in Acute Myeloid Leukemia: A Real-World Single-Center Analysis

Harrison Turner

Poster Presenter: Harrison Turner

Thumbnail for Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

AML - 1113

Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

Ashlyn O'Leary

Poster Presenter: Ashlyn O'Leary

Thumbnail for Transcriptomic Identification of Ferroptosis-Associated Prognostic Signatures in Acute Myeloid Leukemia

AML - 1130

Transcriptomic Identification of Ferroptosis-Associated Prognostic Signatures in Acute Myeloid Leukemia

Punitha Muruganantham

Poster Presenter: Punitha Muruganantham

Thumbnail for Acquired Factor XIII Deficiency in Myeloid Malignancies: An Underrecognized Cause of Severe Hemorrhagic Complications

AML - 1150

Acquired Factor XIII Deficiency in Myeloid Malignancies: An Underrecognized Cause of Severe Hemorrhagic Complications

Alfadil Haroon

Poster Presenter: Alfadil Haroon

Thumbnail for Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

AML - 1153

Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Trends, Predictors, and Outcomes of Do-Not-Resuscitate Status Among Adults Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2016-2022

AML - 1160

Trends, Predictors, and Outcomes of Do-Not-Resuscitate Status Among Adults Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2016-2022

Ameerdad Khan

Poster Presenter: Ameerdad Khan

Thumbnail for TP53 Functional Classification Association With Response and Survival Outcomes in AML and High-Risk MDS

AML - 117

TP53 Functional Classification Association With Response and Survival Outcomes in AML and High-Risk MDS

Qi Tatarata

Poster Presenter: Qi Tatarata